CDH17 expression was retained in thirteen of 14 (93%) CD-associated adenocarcinomas and ≥ 40% extent expression was seen in 12 cases (86%), 9 of them showed ≥ 75% extent expression. Here, CDH17 is linked to adenocarcinoma.